Phase II trial of PENAO in combination with mTOR inhibitor
Latest Information Update: 16 Sep 2019
At a glance
- Drugs PENAO (Primary) ; MTOR protein inhibitors
- Indications Cancer; Solid tumours
- Focus Therapeutic Use
Most Recent Events
- 16 Sep 2019 New trial record
- 21 Aug 2018 According to a Beroni Group media release, Beroni has collaboration with a medical group in Japan with extensive hospital and clinical trial facilities. Conducting part of the clinical trials in Japan will strengthen Beroni's application for Japan PMDA's approval of the PENAO drug.
- 21 Aug 2018 According to a Beroni Group media release, Once the trial has commenced the project team will monitor the progress of these trial sites and more trial sites will be added if necessary to accelerate progress of the clinical trial, particularly in jurisdictions with suitable drug regulation, unmet market need and strong existing collaboration